Denver Daily: Federal Lobbying Heats Up and Colorado Safety Audits

Federal Reform Efforts Gain Traction

As we head into the final stretch of October 2026, the conversation surrounding federal cannabis reform is intensifying. A major civil rights coalition, The Leadership Conference on Civil and Human Rights, has officially disclosed lobbying efforts in the U.S. Senate in support of the Cannabis Administration and Opportunity Act [1]. This push aims to remove marijuana from the Controlled Substances Act and expunge past federal convictions, signaling a significant move by national organizations to prioritize legalization on the federal agenda [1].

Colorado Product Safety Under Review

Closer to home, the Colorado cannabis industry is navigating the fallout from a recent state audit [2]. The Colorado Office of the State Auditor released a report identifying gaps in the state’s marijuana product safety framework, specifically noting the lack of a fully functional state reference lab [2]. While the report acknowledges that the current system provides some baseline assurances, it highlights deficiencies that could limit the state's ability to identify and respond to health and safety risks [2]. Industry stakeholders are watching closely to see how regulators will address these gaps to ensure consumer safety remains a top priority in our mature market [2, 10].

Market Shifts and Industry News

Beyond policy, the business landscape continues to evolve. Spherex has recently moved toward a vertically integrated model by acquiring two Colorado cultivation facilities from The Cannabist Company [5, 10]. Meanwhile, national trends show a decline in marijuana-related emergency medical responses, with a federally funded report noting a 15% drop nationwide between early 2024 and June 2026 [1]. As we look toward the end of the year, businesses are also preparing for upcoming federal changes regarding hemp-derived products, with new shipping policies and regulatory definitions set to take effect in the coming months [5, 7].